Hospitalisation (any cause) · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Heart failure hospitalisation (RR) · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Worsening heart failure · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Worsening kidney function · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hypotension · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hyperkalaemia · heart failure with chronic kidney disease
CHRONIC: Aldosterone antagonists may leads to higher hyperkalaemia compared with placebo (low certainty).
1 finding from 1 review
Quality of life · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Aldosterone antagonists plus loop diuretics plus albumin (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics plus albumin (No direct… (very low certainty).
1 finding from 1 review
HR 1.06 [0.57, 2.16]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics plus peritoneovenous shunt (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics plus peritoneovenous… (very low certainty).
1 finding from 1 review
HR 0.97 [0.4, 2.43]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics plus systemic vasoconstrictors (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics plus systemic… (very low certainty).
1 finding from 1 review
HR 0.42 [0.15, 1.22]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists (No direct RCT) (very low certainty).
1 finding from 1 review
HR 1.92 [0.24, 20.64]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics plus systemic vasoconstrictors plus paracentesis plus fluid replacement (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics plus systemic… (very low certainty).
1 finding from 1 review
HR 1.11 [0.02, 39.77]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics plus systemic vasoconstrictors plus systemic vasodilator (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics plus systemic… (very low certainty).
1 finding from 1 review
HR 0.61 [0.02, 9.17]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics plus systemic vasodilator (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics plus systemic… (very low certainty).
1 finding from 1 review
HR 0.62 [0.03, 9.1]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics (1 RCT; 41 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics (1 RCT; 41 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Aldosterone antagonists plus loop diuretics (2 RCT; 84 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics (2 RCT; 84 participants) (very low certainty).
1 finding from 1 review
OR 3.54 [0.43, 27.41]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics (1 RCT; 31 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics (1 RCT; 31 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Aldosterone antagonists plus loop diuretics (3 RCTs; 125 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics (3 RCTs; 125 participants) (very low certainty).
1 finding from 1 review
HR 1.1 [0.12, 10.74]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics (4 RCTs; 211 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics (4 RCTs; 211 participants) (very low certainty).
1 finding from 1 review
HR 1.05 [0.7, 1.69]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus paracentesis plus fluid replacement (1 RCT; 36 participants) · people with liver cirrhosis and ascites
The intervention may leads to higher aldosterone antagonists plus paracentesis plus fluid replacement (1… (low certainty).
1 finding from 1 review
HR 30.63 [5.06, 692.98]
Studies not reported
Low